Namolife Pharma Private Limited

Namolife Pharma Private Limited - non-profit organizations in Varanasi, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U85300UP2017PTC090196 Incorporated 08 February 2017 ROC Kanpur HQ Varanasi, Uttar Pradesh, India
Active Private Limited Company non-profit organizations MSME · Micro
Data last updated
Revenue · FY 2023
₹17.8 Lakh
▼ 31% YoY
Net loss · FY 2023
₹200
Net margin 0%
EBITDA · FY 2023
₹2,101
EBITDA margin 0.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Namolife Pharma Private Limited

Data last updated:

Namolife Pharma Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India. It operates in the social services and community development segment of the non-profit sector. It was incorporated on 08 February 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U85300UP2017PTC090196. Its GSTIN is 09AAFCN4769H1Z0 (Uttar Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandan Singh and Manisha Singh.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Arazi No. 24/2 Maheshpur Shivpur, Varanasi, Uttar Pradesh, India – 221001.

As per the financials filed for FY 2023, the company reported a revenue of ₹17.8 Lakh, a decline of 31% compared to the previous year. For the same year it recorded a net loss of ₹200 (net margin 0%) and EBITDA of ₹2,101 (EBITDA margin 0.1%).

Namolife Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-75-0001960). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U85300UP2017PTC090196
Registration Number 090196
Incorporation Date 08 February 2017
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-75-0001960

Recognitions & Rankings of Namolife Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2020-21)
Udyam number
UDYAM-UP-75-0001960

Contact details

Namolife Pharma Private Limited's registered office is in Varanasi, Uttar Pradesh. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Arazi No. 24/2 Maheshpur Shivpur, Varanasi, Uttar Pradesh, India – 221001
  • Industry
    Non-Profit Organizations, Social Work

To see the full contact details of Namolife Pharma Private Limited, buy the company report.

Comprehensive company report
Namolife Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Namolife Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Namolife Pharma Private Limited, buy the company report.

Financials of Namolife Pharma Private Limited

FY 2025 filings available

Namolife Pharma Private Limited reported revenue of ₹17.8 Lakh (down 31% YoY) for FY 2023.

Revenue · FY 2023
₹17.8 Lakh ▼ 31%
Net loss · FY 2023
₹200 margin 0%
EBITDA · FY 2023
₹2,101 margin 0.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 31%
EBITDA CAGR growth
1 year
▲ 172%
3 years · compounded
▲ 34%
5 years · compounded
▲ 19%

Revenue fell 31% in the latest year. EBITDA rose 172% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2,101
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹200
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin0.1%
Net Profit Margin0%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Namolife Pharma Private Limited, buy the company report.

Board of directors of Namolife Pharma Private Limited

Namolife Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Manisha SinghAdditional Director06 Jan 20206 Years 9 MonthsCurrent
Chandan SinghDirector08 Feb 20179 Years 8 MonthsCurrent

Peer comparison

Namolife Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Adonia Infrastructure Private Limited₹17.81 Lakh (FY 2024)-29.0%Kolkata, West Bengal, India
Panexus Acipl Chemicals Private Limited₹17.8 Lakh (FY 2024)-55.0%Mumbai, Maharashtra, India
Glareo Labs Private Limited₹17.8 Lakh (FY 2025)3.0%New Delhi, Delhi, India
Elixir Vitae Pharmaceuticals Private Limited₹17.8 Lakh (FY 2024)31.0%Lucknow, Uttar Pradesh, India
Sunrise Autocare Private Limited₹17.8 Lakh (FY 2024)-45.0%Patna, Bihar, India
Namolife Pharma Private Limitedthis company₹17.8 Lakh (FY 2023)-₹2000%-31.0%Varanasi, Uttar Pradesh, India
Ramasharyvision Enterprises Private Limited₹17.8 Lakh (FY 2021)213.0%Varanasi, Uttar Pradesh, India
Hexcy Pharmaceutical Private Limited₹17.8 Lakh (FY 2019)New Delhi, Delhi, India
Kaiyaan Lighting Solutions Private Limited₹17.79 Lakh (FY 2025)47.0%Chennai, Tamil Nadu, India
Thendral Organic Private Limited₹17.79 Lakh (FY 2024)78.0%Srirangam, Tamil Nadu, India
Omsaicreations Fabricon & Exports Private Limited₹17.79 Lakh (FY 2025)-90.0%Kolkata, West Bengal, India

To see the full peer comparison of Namolife Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Namolife Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Namolife Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAFCN4769H1Z0Uttar PradeshActive04 May 2021

To see the full GST registrations and return filing status of Namolife Pharma Private Limited, buy the company report.

Recent activity

Namolife Pharma Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Anand Singh ceased to be Director on 04 Feb 2021.

AGM
Namolife Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Namolife Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Anand Singh ceased to be Director.
Appointed
Manisha Singh was appointed as Additional Director.
Appointed
Chandan Singh was appointed as Director.
Incorporation
08 Feb 2017
Namolife Pharma Private Limited was registered on 08 Feb 2017 with Roc Kanpur & aged 9 years 8 months as per MCA records.

Frequently asked questions

Namolife Pharma is an active private limited company based in Varanasi, Uttar Pradesh, India. The company works in social work, within the non-profit organizations industry. It was incorporated on 08 February 2017 (9+ years old) and is registered under CIN U85300UP2017PTC090196.

Namolife Pharma has 2 current directors:

The latest financial statements of Namolife Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Namolife Pharma is 09AAFCN4769H1Z0, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Namolife Pharma is U85300UP2017PTC090196. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Namolife Pharma was incorporated on 08 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.

The peers of Namolife Pharma by revenue are Adonia Infrastructure Private Limited, Panexus Acipl Chemicals Private Limited, Glareo Labs Private Limited, Elixir Vitae Pharmaceuticals Private Limited, Sunrise Autocare Private Limited and 5 more, all in the same principal business activity (wholesale trading).

Anand Singh ceased to be Director on 04 Feb 2021. Manisha Singh was appointed as Additional Director on 06 Jan 2020. Chandan Singh was appointed as Director on 08 Feb 2017.

Yes, Namolife Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-75-0001960).

The registered office of Namolife Pharma is at Arazi No. 242 Maheshpur Shivpur, Varanasi, Uttar Pradesh, India – 221001.

Namolife Pharma operates in the non-profit organizations industry, in the social work segment.